Amanote Research
Register
Sign In
Kaposi Sarcoma–associated Herpes Virus (KSHV; HHV-8) as a Biomarker for Castration-Resistant Prostate Cancer (CRPC)
Science-Business eXchange
doi 10.1038/scibx.2013.1149
Full Text
Open PDF
Abstract
Available in
full text
Date
October 1, 2013
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Kaposi Sarcoma-Associated Herpesvirus (KSHV) Induces a Functional Tumor-Associated Phenotype for Oral Fibroblasts
Cancer Letters
Cancer Research
Oncology
Guideline Adherence in Docetaxel Treatment of Castration Resistant Prostate Cancer (CRPC) Patients in a Real-World Population: The Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
LINE-1 as a Therapeutic Target for Castration-Resistant Prostate Cancer
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Alkaline Phosphatase in Metastatic Castration-Resistant Prostate Cancer: Reassessment of an Older Biomarker
Future Oncology
Medicine
Cancer Research
Oncology
Ailanthone: A New Potential Drug for Castration-Resistant Prostate Cancer
Chinese Journal of Cancer
Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi’s Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells
Frontiers in Microbiology
Microbiology
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) Guidelines for the Management of Castration-Resistant Prostate Cancer (CRPC)
Canadian Urological Association Journal
Urology
Targeting TCTP as a New Therapeutic Strategy in Castration-Resistant Prostate Cancer
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
